Which is the best model to assess risk for venous thromboembolism in hospitalised patients?

BMJ. 2021 May 27:373:n1106. doi: 10.1136/bmj.n1106.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibrinolytic Agents
  • Hospitalization*
  • Humans
  • Patient Selection
  • Risk Assessment
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / etiology*
  • Venous Thromboembolism / prevention & control

Substances

  • Fibrinolytic Agents